NCT07578870 Effects of Balloon Blowing Therapy and Bubble PEP on Oxygen Saturation, Dyspnea, and Enjoyment in Pediatric Pneumonia
| NCT ID | NCT07578870 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Pneumonia in Children |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2026-04-14 |
| Primary Completion | 2026-05-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2026-04-14 with a primary completion date of 2026-05-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Pneumonia is a major cause of illness and death in children, leading to breathing difficulties and reduced oxygen levels due to impaired gas exchange. Non-pharmacological techniques like balloon blowing and Bubble PEP are simple, engaging methods used to improve respiratory function. This randomized clinical trial will compare the effects of Balloon Blowing Therapy and Bubble PEP on oxygen saturation, dyspnea, and enjoyment in 40 children with pediatric pneumonia over one week.
Eligibility Criteria
Inclusion Criteria: * Children aged 6 to 12 years * Medically stable and cleared to perform breathing exercises * Both genders will be included * Presence of dyspnea according to the patient's statement * Peripheral oxygen saturation (SpO2) \<94% Exclusion Criteria: * Children who are critically ill patients on bi-pep or a ventilator, as well as patients who were intubated and uncooperative * Children with any oral surgery * Participants were excluded from the study, if they had any contraindication to the use PEP therapy (severe haemoptysis) * Refusal to participate or inability to complete full sessions
Contact & Investigator
Mahnoor ikram, MS-PT
PRINCIPAL INVESTIGATOR
Riphah International University
Frequently Asked Questions
Who can join the NCT07578870 clinical trial?
This trial is open to participants of all sexes, aged 6 Years or older, up to 12 Years, studying Pneumonia in Children. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07578870 currently recruiting?
Yes, NCT07578870 is actively recruiting participants. Contact the research team at imran.amjad@riphah.edu.pk for enrollment information.
Where is the NCT07578870 trial being conducted?
This trial is being conducted at Lahore, Pakistan.
Who is sponsoring the NCT07578870 clinical trial?
NCT07578870 is sponsored by Riphah International University. The principal investigator is Mahnoor ikram, MS-PT at Riphah International University. The trial plans to enroll 40 participants.